$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
雷沙吉兰是否进入医保?
2025-10-19 11:44:20
Check Details
雷沙吉兰治疗帕金森的患者疗效好吗?
2025-10-19 11:44:20
Check Details
帕金森患者用雷沙吉兰治疗的效果
2025-10-19 11:44:20
Check Details
雷沙吉兰治疗帕金森的效果怎么样呢?
2025-10-19 11:44:20
Check Details
雷沙吉兰纳入医保目录了没?
2025-10-19 11:44:20
Check Details
雷沙吉兰在治疗帕金森这方面效果怎么样?
2025-10-19 11:44:20
Check Details
雷沙吉兰治疗帕金森患者效果怎样?
2025-10-19 11:44:20
Check Details
雷沙吉兰治疗帕金森疗效咋样?
2025-10-19 11:44:20
Check Details
安齐来多少钱一盒?
2025-10-19 11:44:20
Check Details
安齐来一个月吃几盒?
2025-10-19 11:44:20
Check Details
安齐来一盒多少片?
2025-10-19 11:44:20
Check Details
安齐来服用方法
2025-10-19 11:44:20
Check Details
1
2
...
3344
3345
3346
3347
3348
3349
3350
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
2
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
3
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
4
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
5
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
6
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
7
Elagolix for Endometriosis Pain: Indications and Usage Guidelines
8
Bosentan vs. Antihypertensives: What PAH Patients Need to Know
9
Letermovir: Proper Usage and Important Precautions
10
FDA Approves Daraxonrasib, Marking Milestone in Metastatic Pancreatic Cancer Treatment
11
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
12
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas